In just 10 years, annual 340B purchases grew more than 700%, from $7.5 billion in 2013 to $53.7 billion in 2022. Factors underlying this growth include. Exponential growth in participation by non ...

No one seems as surprised about the effort as the lawmakers themselves. The video ad by Building America’s Future is titled ...

The 340B Drug Pricing Program (340B) is a cornerstone of equitable healthcare in the U.S. For more than 30 years, it has ensured that drug manufacturers provide discounted medications to ...

In their joint lawsuit, Amgen, Eli Lilly and Company, and UCB claim several Nevada STD clinics were unlawfully qualified for the federal drug discount program, 340B, giving them access to millions ...